2025 Event Recap
Goodwin + KPMG 6th Annual Symposium @ JP Morgan
Goodwin and KPMG hosted our 6th Annual Symposium on January 15, 2025, during the 43rd Annual JP Morgan Healthcare Conference.
Life sciences companies have many opportunities to thrive in the face of changing tides. At this year's symposium, we delved into strategies that enable them to enhance research and development; optimize value from licensing, M&A, and other transactions; and secure capital for growth. By embracing these opportunities, life sciences companies can avoid getting caught in a riptide and chart new paths to success.
See you at the next one!
Featured Insights
How the Trump Administration Could Reshape Regulation in the Life Sciences Sector
Six areas in which emerging policy suggest significant changes for biotech, pharmaceutical, and medical device companies.
Life Sciences M&A Boom and Other Trends to Watch in 2025
Learn more about significant developments expected for the life sciences sector in 2025.
Six Hot Trends in Life Sciences for 2025
See what to expect when it comes to investor interest, AI, and more.
2025 Agenda & Videos
Dive Deeper with Goodwin
Goodwin's Life Sciences Practice
Our Life Sciences practice is uniquely positioned to partner with innovators and investors operating in a fast-moving, technology-driven environment. We work with life sciences companies throughout the corporate lifecycle, as well as with investors, banks, and others in the life sciences ecosystem.
Life Sciences Perspectives
Our Life Sciences Perspectives blog is a resource specifically aimed at addressing your most frequent and pressing issues in this dynamic industry. We provide the insights you need most, including developments on private and public company matters, licensing deals and collaborations, patent and IP matters, FDA and healthcare regulatory compliance, and European and Asian developments for life sciences companies.
Get In Touch
For more information about our annual Symposium, please email us.